← back to search

Constantin T. Yiannoutsos

City University of New York · US
Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV/AIDS Research and Interventions, HIV Research and Treatment, HIV/AIDS drug development and treatment, and HIV-related health complications and treatments.
h-index
70
citations
15,572
works
298
NIH funding
primary concept
Medicine
email

Recent publications

Cohort profile: measuring adverse pregnancy and newborn congenital outcomes (MANGO) study in Kenya
BMJ Open 2025cited by 2position: middledoi
Distal and Proximal Influences on Self-Reported Oral Pain and Self-Rated Oral Health Status in Saudi Arabia: Retrospective Study Using a 2017 Nationwide Database.
2024cited by 3position: contributordoi
Assessing HIV-infected patient retention in a program of differentiated care in sub-Saharan Africa: a G-estimation approach.
2024cited by 1position: contributordoi
Real-World Cervical Cancer Screening Uptake and Predictors of Visual Inspection With Acetic Acid Positivity Among Women Living With HIV in Care Programs in Western Kenya.
2024cited by 1position: contributordoi
Distal and Proximal Influences on Self-Reported Oral Pain and Self-Rated Oral Health Status in Saudi Arabia: Retrospective Study Using a 2017 Nationwide Database (Preprint)
2023cited by 0position: contributordoi
Virologic non-suppression and early loss to follow up among pregnant and non-pregnant adolescents aged 15-19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study.
2022cited by 10position: contributordoi
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
2021cited by 67position: contributordoi
Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression
PLoS ONE 2021cited by 52position: middledoi
Infection Fatality Ratios for COVID-19 Among Noninstitutionalized Persons 12 and Older: Results of a Random-Sample Prevalence Study.
2021cited by 21position: contributordoi
Bayesian estimation of SARS-CoV-2 prevalence in Indiana by random testing.
2021cited by 16position: contributordoi
Global HIV mortality trends among children on antiretroviral treatment corrected for under-reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration.
2021cited by 15position: contributordoi
Achieving consistency in measures of HIV-1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort data.
2021cited by 8position: contributordoi
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study
2020cited by 20position: contributordoi
Lower rates of ART initiation and decreased retention among ART-naïve patients who consume alcohol enrolling in HIV care and treatment programs in Kenya and Uganda.
2020cited by 10position: contributordoi
A semiparametric method for the analysis of outcomes during a gap in HIV care under incomplete outcome ascertainment
Statistical Communications in Infectious Diseases 2020cited by 1position: contributordoi
PS-SiZer map to investigate significant features of body-weight profile changes in HIV infected patients in the IeDEA Collaboration.
2020cited by 0position: contributordoi
Changes in rapid HIV treatment initiation after national “treat all” policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis
PLoS Medicine 2019cited by 84position: middledoi
Changes in rapid HIV treatment initiation after national "treat all" policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis.
2019cited by 65position: contributordoi
Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study
The International Journal of Biostatistics 2019cited by 42position: middledoi
Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa
BMC Cancer 2017cited by 20position: middledoi
Facility-Level Factors Influencing Retention of Patients in HIV Care in East Africa
PLoS ONE 2016cited by 63position: middledoi
A prospective ascertainment of cancer incidence in sub‐Saharan Africa: The case of Kaposi sarcoma
Cancer Medicine 2016cited by 60position: middledoi
Retention in Care and Patient-Reported Reasons for Undocumented Transfer or Stopping Care Among HIV-Infected Patients on Antiretroviral Therapy in Eastern Africa: Application of a Sampling-Based Approach
Clinical Infectious Diseases 2015cited by 167position: middledoi
Estimation of mortality among HIV-infected people on antiretroviral treatment in east Africa: a sampling based approach in an observational, multisite, cohort study
The Lancet HIV 2015cited by 90position: middledoi
Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy
JAIDS Journal of Acquired Immune Deficiency Syndromes 2015cited by 63position: middledoi
Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection
PLoS ONE 2014cited by 118position: middledoi
Failure to Initiate Antiretroviral Therapy, Loss to Follow-up and Mortality Among HIV-Infected Patients During the Pre-ART Period in Uganda
JAIDS Journal of Acquired Immune Deficiency Syndromes 2013cited by 93position: middledoi
Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy
Journal of NeuroVirology 2013cited by 76position: middledoi
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
Journal of Neuroinflammation 2013cited by 69position: middledoi
Neurovirological Correlation With HIV-Associated Neurocognitive Disorders and Encephalitis in a HAART-Era Cohort
JAIDS Journal of Acquired Immune Deficiency Syndromes 2012cited by 126position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 15 papers (2019–2024)Kara Wools‐Kaloustian · AMPATH8 papers (2015–2025)Mwebesa Bwana · Indiana University – Purdue University Indianapolis6 papers (2013–2017)Jeffrey N. Martin · Global Solutions for Infectious Diseases5 papers (2013–2017)David V. Glidden · San Francisco General Hospital5 papers (2013–2017)Megan Wenger · University of California, San Francisco4 papers (2015–2017)Nir Menachemi · Indiana University4 papers (2020–2021)Elvin Geng · Washington University in St. Louis4 papers (2013–2016)Andrew Kambugu · Indiana University – Purdue University Indianapolis4 papers (2015–2016)Winnie Muyindike · Indiana University – Purdue University Indianapolis3 papers (2013–2016)Richard W. Price · San Francisco General Hospital3 papers (2013–2021)Dietmar Fuchs · German Primate Center3 papers (2013–2021)Serena Spudich · Yale University3 papers (2013–2021)Paul K. Halverson · University of North Carolina at Chapel Hill3 papers (2020–2021)Mary-Ann Davies · Africa University3 papers (2019–2022)Beverly S. Musick · Indiana University School of Medicine3 papers (2020–2024)Elyse J. Singer · University of California, Los Angeles3 papers (2012–2015)Beverly Musick · Indiana University School of Medicine3 papers (2016–2025)Lars Hagberg · Sahlgrenska University Hospital3 papers (2013–2021)Elizabeth A. Bukusi · University of California, San Francisco3 papers (2015–2016)